Thor talks psychedelics and drug risk reality with, Anne Schlag. Head of Research and acting CEO at Drug Science, Honorary Fellow at Imperial College London and a senior colleague of David Nutt.

To become a ⁠Drug Science member go here⁠ today

Drug Science paper on adverse effects of psychedelics

The Australia story: Current status and future challenges for the clinical applications of psychedelics Australian developments

Thor Holt welcomes your connection here on LinkedIn